Trials / Not Yet Recruiting
Not Yet RecruitingNCT07365397
Imaging Characteristics of Different ⁶⁸Ga-PSMA Probes in Prostate Cancer
Comparative Study on Imaging Characteristics of Different ⁶⁸Ga-Labeled PSMA Probes in Patients With Prostate Cancer
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the imaging characteristics of \[⁶⁸Ga\]Ga-GS24-B2-250-T Injection (abbreviated as ⁶⁸Ga-GS24-B2-250-T), \[⁶⁸Ga\]Ga-GS24-B2-268-T Injection (abbreviated as ⁶⁸Ga-GS24-B2-268-T), \[⁶⁸Ga\]Ga-GS24-B2-237-T Injection (abbreviated as ⁶⁸Ga-GS24-B2-237-T), and \[⁶⁸Ga\]Ga-PSMA-11 Injection (abbreviated as ⁶⁸Ga-PSMA-11) as PET/CT imaging agents in patients with prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 68Ga-GS24-B2-268-T | detect prostate cancer lesions via 68Ga-GS24-B2-268-T PET/CT imaging |
| DIAGNOSTIC_TEST | 68Ga-GS24-B2-250-T | detect prostate cancer lesions via 68Ga-GS24-B2-250-T PET/CT imaging |
| DIAGNOSTIC_TEST | 68Ga-GS24-B2-237-T | detect prostate cancer lesions via 68Ga-GS24-B2-237-T PET/CT imaging |
| DIAGNOSTIC_TEST | 68Ga-PSMA-11 | detect prostate cancer lesions via 68Ga-PSMA-11 PET/CT imaging |
Timeline
- Start date
- 2026-01-19
- Primary completion
- 2026-06-14
- Completion
- 2026-07-26
- First posted
- 2026-01-26
- Last updated
- 2026-01-26
Source: ClinicalTrials.gov record NCT07365397. Inclusion in this directory is not an endorsement.